The impact of protein expression in AML has long been studied, with an early focus on proteins involved in chemotherapy resistance, such as P-glycoprotein (the MDR1 gene product), whose hyperexpression was mostly associated with worse prognosis [185,186]. This evidence concerns the gene ABCB1 and acute myeloid leukemia.